Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (32)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Busacca, M.
Right arrow Articles by Vignali, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Busacca, M.
Right arrow Articles by Vignali, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 16, No. 11, 2399-2402, November 2001
© 2001 European Society of Human Reproduction and Embryology

Post-operative GnRH analogue treatment after conservative surgery for symptomatic endometriosis stage III–IV: a randomized controlled trial

M. Busacca,1, E. Somigliana, S. Bianchi, S. De Marinis, C. Calia, M. Candiani and M. Vignali

II Department of Obstetrics and Gynecology, University of Milano, Milan, Italy1To whom correspondence should be addressed at: II Department of Obstetrics and Gynecology, Clinica `L. Mangiagalli', Via Commenda 12, 20122, Milano, Italy.

BACKGROUND: In order to decrease endometriosis recurrence after surgical therapy, it has been proposed to use a post-surgical oestrogen-lowering medical treatment. Results from previous trials on this topic are contradictory. METHODS: A total of 89 women were randomized, by computer-generated list, after laparoscopic conservative surgery for symptomatic endometriosis stage III–IV to receive monthly i.m. injections of gonadotrophin-releasing hormone (GnRH) analogue, leuprolide acetate depot (3.75 mg) for 3 months (n = 44) or to an expectant management (n = 45). All patients were followed up every 6 months for evaluation of pain symptoms, fertility and objective disease recurrence. RESULTS: During the follow-up, which ranged from 6–36 months, five (33%) of the 15 women who wanted children and who were allocated the GnRH analogue and six (40%) of the 15 given no treatment became pregnant (not significant). Moderate/severe pelvic pain recurred during the follow-up in 10 (23%) of the women allocated the GnRH analogue and 11 (24%) of those allocated no treatment; the cumulative pain recurrence rates at 18 months were 23 and 29% respectively (not significant). Four women (9%) treated with GnRH analogue and four women (9%) who received no treatment had objective disease recurrence as demonstrated by gynaecological examination and/or pelvic ultrasonography. CONCLUSIONS: This study does not support the routine post-operative use of a 3 month course of GnRH analogue in women with symptomatic endometriosis stage III–IV.

Key words: endometriosis/gonadotrophin-releasing hormone analogue/laparoscopy

1 E-mail: auro.busacca{at}unimi.it


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
The Obstetrician and GynaecologistHome page
N. Kenney and J. English
Surgical management of endometriosis
Obstet Gynaecol (Lond), July 1, 2007; 9(3): 147 - 152.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
K. Koga, Y. Takemura, Y. Osuga, O. Yoshino, Y. Hirota, T. Hirata, C. Morimoto, M. Harada, T. Yano, and Y. Taketani
Recurrence of ovarian endometrioma after laparoscopic excision
Hum. Reprod., August 1, 2006; 21(8): 2171 - 2174.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Kennedy, A. Bergqvist, C. Chapron, T. D'Hooghe, G. Dunselman, R. Greb, L. Hummelshoj, A. Prentice, E. Saridogan, and on behalf of the ESHRE Special Interest Group for
ESHRE guideline for the diagnosis and treatment of endometriosis
Hum. Reprod., October 1, 2005; 20(10): 2698 - 2704.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G. L. Schattman
Treatment of chronic pelvic pain in patients with endometriosis
Hum. Reprod., April 1, 2002; 17(4): 1128 - 1129.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.